Studies have revealed that obesity and eating disorders disrupt the brain's normal response to food entering the stomach and ...

“Securing this patent strengthens our intellectual property portfolio, continuing progress on naronapride’s global clinical development,” said Dr. Peter Milner, M.D., FACC, Chairman and CEO of ...

Bromocriptine is unique in that it does not have a specific receptor that mediates its action on glucose and lipid metabolism. Rather, its effects are mediated via resetting of dopaminergic and ...

As underlined above, although dopamine agonists reduce the risk of motor complications, the inevitable introduction of levodopa might promote the appearance of severe LID 11. D2 receptor agonists ...

Researchers found that caffeine blocks alcohol’s ability to increase dopamine in brain reward areas, potentially reducing ...

At the same time it also avoids stimulating similar receptors, such as the dopamine D2 receptor, that can lead to unwanted side effects. This type of selective dual targeting is a major challenge ...

New Delhi: IQVIA has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control ...

SUMMARY: Notice is hereby given that the Department of Veterans Affairs (VA), Office of Research and Development, Technology ...

New Delhi: The pharmaceutical major Sun Pharma Laboratories has got a go-ahead from the Subject Expert Committee (SEC) ...